scholarly journals Effect of Yoganidra on Blood Pressure, Hs-CRP, and Lipid Profile of Hypertensive Subjects: A Pilot Study

2021 ◽  
Vol 2021 ◽  
pp. 1-9
Author(s):  
J. P. Devraj ◽  
B. Santosh Kumar ◽  
M. Raja Sriswan ◽  
B. Jagdish ◽  
B. S. Priya ◽  
...  

Background. Yoganidra is a systematic method of promoting a state of complete physical, mental, and emotional relaxation. It is a safe, inexpensive, and very effective method of management of hypertension when used along with standard pharmacological therapy. This study aims to assess the effect of yoganidra on blood pressure (both systolic blood pressure (SBP) and diastolic blood pressure (DBP)), Hs-CRP, and lipid profile of hypertensive subjects at the time of enrollment (subjects that are hypertensive at the time of enrollment). Methods. Both treated and untreated subjects (n = 74) with hypertension (blood pressure ≥140/90 mmHg) and age between 35 and 70 years were included in this study after obtaining ICMR-NIN-IEC approval and written informed consent from all subjects. Subjects with critical illness and/or psychological disturbances were excluded from this study. The subjects in the experimental group (n = 31) practiced yoganidra for 45 minutes daily for 12 weeks under strict supervision. There was no intervention in the control group (n = 43). Weekly blood pressure was recorded in the experimental group, whereas it was performed at baseline and at endpoint for control groups. Hs-CRP and lipid profile were estimated at baseline and endpoint for both the groups. Results. A significant reduction in mean SBP from 142.9 mm Hg (SD ± 16.46) to 118.68 mm Hg (SD ± 9.21; p value 0.0001) and DBP from 89.84 mm Hg (SD ± 10.42) to 77.03 mm Hg (SD ± 6.47: p value 0.0001) was observed among the experimental group after 12 weeks of yoganidra practice when compared with the control group. A significant reduction in mean Hs-CRP (2.21 ± 1.49 to 1.06 ± 0.82 mg/L, p  < 0.001 ∗ ∗ ∗ ) was observed among the experimental group. There were no significant differences between triglycerides and total cholesterol levels, whereas LDL-C and HDL-C showed a trend of improvement in the experimental group after intervention. Conclusions. In this pilot study, we observed a significant reduction in blood pressure and Hs-CRP in the yoganidra group compared with the control group. There were no significant side effects observed in the intervention group during the study period.

2020 ◽  
Vol 3 (5) ◽  
pp. 569-575
Author(s):  
Ketut Anom Sri Kesumawati ◽  
Mardiyono Mardiyono ◽  
Leni Latifah

Gestational hypertension (GH) adverse effects on pregnancy and fetal development, but there are still a few non-pharmacological interventions that can control blood pressure. The study aimed to examine the impact of acumoxa therapy on reducing blood pressure among patients with GH. Thirty-four patients were admitted to three community health centers in Brebes Regency. They were selected and randomly divided into two groups, such as the experimental group and the control group. This study's participation was pregnant women randomly allocated to the experimental group (n= 17) and control group (n=17). The intervention group received acumoxa therapy. The control group received acupressure therapy at the same time of 5 minutes at each point in 3 sessions per week for four weeks. The points used between the intervention and control groups were almost the same. Acupoints HT 7 and LI11 are given acumoxa and acupressure. Point GV20 is only covered by pressure, and point KI3 is only moxibustion. Of the 34 women who completed the study, those who received acumoxa had significantly lower mean arterial pressure (MAP) (mean difference = 8 mmHg, p<0.05). Acumoxa therapy is an effective non-pharmacological method for reducing blood pressure in patients with gestational hypertension


Author(s):  
Siska Sakti Anggraini ◽  
Siti Aisyah Nur ◽  
Honesty Diana Morika ◽  
Ratna Indah Sari Dewi

Background: Hypertension is called the silent killer because it does not provide specific symptoms, it can increase the incidence of strokes, heart attacks, chronic kidney disease if not controlled and controlled properly. Management of hypertension is generally with pharmacological therapy that has not shown improvement. Non-pharmacological treatment using rosella flower tea which functions to open blood vessels wider, reduce blood viscosity and increase urine production so as to reduce blood volume. The purpose of this study was to study the effect of rosella tea on reducing blood pressure in hypertensive patients.  Methods: This study uses a quasi-experiment design with the two-group pre-test and post-test design approach. This research was conducted on patients with hypertension at the Padang city health center with an intervention group of 16 respondents and a control of 16 respondents. Data analysis in this study used univariate and bivariate using independent t-test statistics.  Results: The results of the study showed the average blood pressure in the systolic pretest intervention group 147.81 for 94.69 diastole and posttest systole 129.06 posttest diastole 78.75 while the control group for systole pretest 154.6 for diastole 96.25 and posttest without posttest treatment systole 129.06 postest diastole 78.75. Obtained a p value 0,000 statistical test for systole and a p value 0,000 diastole.  Conclusions: There is an effect of rosella flower tea on reducing blood pressure in patients with hypertension at the Padang city health center.


Author(s):  
Kristýna Machová ◽  
Radka Procházková ◽  
Michal Říha ◽  
Ivona Svobodová

A stroke is a condition that can give rise to consequences such as cognitive and physical constraints, which sometimes manifest in the psychological condition of the patient. Such patients commence rehabilitation as soon as is possible, which involves a multi-disciplinary approach to treatment. One aspect of complementary rehabilitation could be animal-assisted therapy (AAT). A total of 15 individuals were split into an experimental group comprising 6 patients (2 males, 4 females), and a control group of 9 patients (3 males, 6 females). The participants in the control group were aged from 43 to 87 years and the experimental group featured participants aged from 45 to 76 years. Both groups received standard physiotherapy and occupational therapy. In addition, the experimental group was supplemented with AAT, with the animal in question being a dog. The tools primarily applied to measure the outcomes were the Barthel index, blood pressure, and heart rate measurements, whereas the Likert scale was employed to discern the mood of the patients. The results showed that changes in the values for heart rate and blood pressure were insignificant. However, a statistically significant aspect of the research pertained to the patients confirming that they felt better after the AAT sessions. Hence, AAT could potentially bolster the effectiveness of other therapies.


2020 ◽  
Vol 9 (2) ◽  
pp. 801-812
Author(s):  
Dwi Apriyani ◽  
Masrifan Djamil ◽  
Suryati Kumorowulan

Post partum hypertension contributes to maternal mortality. Postpartum hypertension management can be in the form of pharmacological therapy, but it causes side effects for mother and baby. Several studies have shown that chayote can play a role in lowering blood pressure. This research aimed to prove the effect of chayote extract on reducing blood pressure in postpartum with hypertension. Quasy experiment pretest and posttest control group design. The number of samples was 19 interventions and 19 controls. The intervention group received 400 mg of chayote extract and 10 mg of nifedipine, while the control group received only 10 mg of nifedipine. The intervention was carried out for 7 days. The treatment group experienced significant changes in systolic blood pressure and diastolic blood pressure with p value = 0.000 compared to the control group. The chayote extract has a significant effect on reducing blood pressure in postpartum with hypertension


2019 ◽  
Vol 5 (2) ◽  
pp. 27-34
Author(s):  
Any Isro'aini

Hypertension in preeclampsia is found in pregnant women with gestational age> 20 weeks. Hypertension is defined where systolic pressure above 140 mmHg and diastolic pressure above 90 mmHg. Handling hypertension in pregnant women up to now is still using pharmacological therapy or drugs by 100%. One nonpharmacological therapy that can lower blood pressure is aromatherapy lavender massage therapy. The purpose of this study was to determine the effect of lavender aromatherapy massage on blood pressure reduction in pregnant women with preeclampsia.The design of this study used the Quasy Experiment Design with the Control Time Series Design research design, where the study used two groups divided into experimental groups and control groups. In this study both groups were pre-tested and after being given treatment in the experimental group a post-test was carried out in both groups. The research sample amounted to 50 respondents, of which 25 respondents became the experimental group and 25 became the control group. This research took place at PBM. Lilis Suryawati, Sambong village, Dukuh, Jombang District, Jombang Regency. This research was conducted from February to April 201.                    The results showed a significant difference between the blood pressure of the experimental group who were treated and the control group that was not treated. The systolic blood pressure of both groups p-value 0.003 and the value of Z -4.007. While diastolic blood pressure in both groups p-value 0,000 and Z value -5,559.                    It is expected that the midwifery profession can provide information about the importance of aromatherapy lavender massage to reduce blood pressure in pregnant women with preeclampsia, so that it can minimize the occurrence of complications in pregnant women with preeclampsia.


2016 ◽  
Vol 13 (3) ◽  
pp. 352-359 ◽  
Author(s):  
Kathy Ruble ◽  
Susan Scarvalone ◽  
Lisa Gallicchio ◽  
Catherine Davis ◽  
Diane Wells

Background:: Inadequate physical activity (PA) in childhood cancer survivors may lead to compromised health outcomes. The purpose of this pilot study was to evaluate the feasibility and effect of a PA intervention in childhood cancer survivors ages 8–12 who report < 1 hour of moderate-to-vigorous physical (MVPA) per day.Methods:Twenty survivors were randomized to a 6-month group PA intervention or to a control group. A pre/post measure of MVPA was completed by all participants, and a pre/post measure of self-efficacy was completed by the intervention group. Analysis included measures of feasibility, change in percentage of awake time spent in MVPA, self-efficacy scores, and correlations in MVPA and self-efficacy.Results:All feasibility parameters were confirmed. Increases in percent of awake time spent in MVPA were seen in 67% of the intervention group and 14% of the control group. A medium effect size (r = 0.55) was calculated for the correlation between change in MVPA and change in total self-efficacy scores; the largest effect size (r = 0.62) was found for the subscale for adequacy.Conclusions:Increases in MVPA can be seen in childhood cancer survivors who participate in a group intervention that includes support of self-efficacy.


2021 ◽  
Vol 16 (1) ◽  
pp. 151-161
Author(s):  
Hendri Budi ◽  
Herwati Herwati

70-94% of acute stroke patients have an increase in blood pressure. Relaxation can be done to treat hypertension. Relaxation in Islam uses zikr (remembering Allah SWT). The purpose of this study was to determine the effect of zikr on reducing blood pressure in acute stroke patients. The research design was quasi-experimental, with two group pretest-posttest design with a control group. The experimental group was given the zikr therapy intervention. The sample of the study was acute stroke patients in the Nervous Room of RSUP Dr. M. Djamil Padang. There were 40 samples, 20 people in the experimental group and 20 people in the control group obtained by purposive sampling. Data collection is September to November 2020 by measuring the patient's blood pressure before and after the intervention. The data is processed manually. Analysis of data with non-parametric Mann Whitney test. The results showed that there was no difference between systolic blood pressure before treatment in the intervention group and the control group (p = 0.976), but there was a difference after treatment (p = 0.000). There was no difference between diastolic blood pressure before treatment in the intervention group and the control group, (p = 0.294), but there was a difference after treatment (p = 0.000). The study concludes that zikr therapy can reduce systolic and diastolic blood pressure in acute stroke patient. It is recommended to the head of the Nerve room to apply zikr therapy in acute stroke patients.


2020 ◽  
Vol 5 (2) ◽  
pp. e21-e21
Author(s):  
Parvin Soltani ◽  
Naser Saeedi ◽  
Navidreza Mashaykhi ◽  
Alireza Rostami ◽  
Maryam Tajfar

Introduction: In spite of widely accepted idea that exercise is beneficial in dialysis, it is not easy to incorporate an exercise program into routine clinical practice of these patients. Objectives: The present study was conducted to evaluate the effects of exercise on hemodialysis patients. Patients and Methods: In this non-pharmacologic clinical trial, a total of 49 clinically stable hemodialysis patients were enrolled in the study and were randomly allocated into two groups; the intervention group (n=27) and the control group (n=22). The intervention group conducted at least 30 minutes of cycling during each hemodialysis session for six months. Intradialytic blood pressure, high-sensitivity C-reactive protein (hs-CRP) blood levels and dialysis adequacy were estimated before and after dialysis. Results: At the end of the 6-month study period, a significant reduction in systolic and diastolic blood pressure in all patients of the intervention group (P<0.05) was detected. Although the dialysis quality increased more than 1.2, it was not statistically significant. Moreover hs-CRP was decreased in the exercise group at the end of the study, while these outcomes were not statistically significant too. Conclusion: Intradialytic exercise can lead to a significant reduction in systolic and diastolic blood pressure in hemodialysis patients. Trial registration: This randomized controlled trial was registered in the Iranian Registry of Clinical Trials (#IRCT2015092324152N1, https://irct.ir/trial/20465, ethical code; ARAKMU.REC.1393.168.1).


2020 ◽  
Vol 9 (2) ◽  
pp. 443-449
Author(s):  
Dina Hanifa ◽  
Suharyo Hadisaputro ◽  
Supriyana Supriyana ◽  
Bedjo Santoso

One third of women who have hypertension in pregnancy will continue to have high blood pressure during the postpartum period. Potential adjuvant pharmacological therapy is needed, one of them is purple yam extract which contains flavonoids and dioscorin. This type of research is a quasi experiment. The research respondents consisted of 16 people treated with purple yam extract 320 mg/day and nifedipine 10 mg/day and 16 people were given nifedipin 10 mg/day for 14 days. The results of the study were the systolic of the intervention group decreased by 28.12 mmHg and the control group decreased by 8.94 mmHg with a p-value of 0,000. The diastolic of the intervention group decreased by 18.43 mmHg and the control group decreased by 3.75 mmHg with a p-value of 0,000. The conclusion of this study is purple yam extract has the potential as an alternative therapy to reduce blood pressure in postpartum hypertension.


2018 ◽  
Author(s):  
Xuyong Chen ◽  
Shasha Xie ◽  
Xiaojuan Yu ◽  
Zhibin Chen ◽  
Min Zhuo ◽  
...  

BACKGROUND The prevalence of chronic kidney disease (CKD) is approximately 850 million worldwide and 120 million in China. Approximately 2% of the CKD population will progress to end-stage renal disease (ESRD) requiring renal replacement therapy or transplantation. The total health care expenditure on dialysis for the entire ESRD population in China is estimated to be 240 billion RMB per year. Using mobile health information technologies to conduct low-cost, large-scale, and personalized populational health interventions show a great promise. OBJECTIVE In this pilot study, we assessed the feasibility and clinical effectiveness of a mobile application designed to improve patient's self-management of chronic kidney disease over a 3-month intervention with a pre-post design and a quasi-trial design. METHODS Patients with CKD stage 1-3 and uncontrolled proteinuria (proteinuria>1g per day) were recruited. Eligible patients who were waitlisted served as the control. Patients in the experiment group were invited to install a mobile application known as Shen Shang Xian (Chinese pinyin for kidney online) for CKD self-management. The enrollment included a questionnaire for medical history and self-reported objective physical parameters and laboratory values. Each participant was assigned to one nephrologist who communicated with the patient on an ad-hoc basis. Blood pressure and laboratory test results were entered by the patients on a regular basis. The application has a built-in clinical decision algorithm to generate health recommendations to users based on one's data-entry. The application also sends various alerts to patient's nephrologist for timely interventions. Blood pressure, proteinuria, serum creatinine and eGFR were measured before and after the management period. RESULTS Fifty-three patients were enrolled in the experimental group and 11 patients were in the control group. The average daily usage in minutes was 11.2 (25%-75% quartile [7.5, 16]) and the average of total physician-patient conversation was 116 (25%-75% quartile [51, 274]). There is a significant correlation between average daily usage and physician-patient conversation (R2=0.30, P<.001). The starting eGFR was 102 ml/1.73cm2 (95% CI 92-105]) in the experimental group and 118 ml/1.73cm2 (95% CI 100-134]) in the control group (P=.04). The body mass index (BMI), blood pressure, and proteinuria had no statistical significance. At the end of the study, the mean change of proteinuria was -1.39 g (95% CI -2.07 to -0.72]) in the experimental group and 0.37 g (95% CI -2.11-2.85]) in the control group (P=.14). After adjusted for ACEi/ARB use, the mean change of proteinuria was -1.46 vs 0.47 in the experimental group vs the control group respectively (P=.16). The eGFR was not changed at the end of the study. There was no correlation between the average daily use and change of proteinuria. CONCLUSIONS Participants used the mobile app on a daily basis and communicated with the nephrologists for their CKD management. Patients who used the CKD self-management app exhibited a non-statistically significant trend of proteinuria reduction after 3 months. This pilot study was underpowered and the follow-up period was short. A larger retrospective controlled trial is needed to confirm the effectiveness of mHealth app in CKD self-management.


Sign in / Sign up

Export Citation Format

Share Document